News + Filings Transactions Holdings
|
New Enterprise Associates 16, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/30/2022 | Akouos, Inc. | AKUS | Other | Common Stock | 4.3M | $0.00 | $0 | | 11/30/2022 |
| 05/25/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Sale | Common Stock | 4.4M | $0.08 | $362.7k | | 05/24/2022 |
| 05/24/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Sale | Common Stock | 5.9M | $0.07 | $387.9k | | 05/24/2022 |
| 04/11/2022 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 2.6M | $1.90 | $5M | | 04/11/2022 |
| 12/22/2021 | Metacrine, Inc. | MTCR | Sale | Common Stock | 288.8k | $1.00 | $289.3k | | 12/10/2021 |
| 12/22/2021 | Metacrine, Inc. | MTCR | Sale | Common Stock | 170.9k | $0.91 | $155.6k | | 12/10/2021 |
| 12/10/2021 | Metacrine, Inc. | MTCR | Sale | Common Stock | 37.6k | $1.32 | $49.6k | | 12/10/2021 |
| 10/18/2021 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 1.9M | $0.00 | $0 | | 10/18/2021 |
| 10/18/2021 | Trevi Therapeutics, Inc. | TRVI | Purchase | 7-Year Common Stock Warrant | 1.9M | $1.37 | $2.5M | | 10/18/2021 |
| 03/16/2021 | Marker Therapeutics, Inc. | MRKR | Purchase | Common Stock | 5.7M | $1.75 | $10M | | 03/16/2021 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common Stock | 333k | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Purchase | Common Stock | 769.2k | $13.00 | $10M | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series B Convertible Preferred Stock | 2M | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series C Convertible Preferred Stock | 333k | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common Stock | 2M | $0.00 | $0 | | 09/18/2020 |
| 07/24/2020 | GENOCEA BIOSCIENCES, INC. | GNCA | Purchase | Common Stock | 3.2M | $2.25 | $7.1M | | 07/24/2020 |
| 07/24/2020 | GENOCEA BIOSCIENCES, INC. | GNCA | Purchase | Warrant to Purchase Common Stock | 3.2M | $2.25 | $7.1M | | 07/24/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series B Preferred Stock | 1.2M | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series A Preferred Stock | 2M | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series Seed Preferred Stock | 513.8k | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Purchase | Common Stock | 588.2k | $17.00 | $10M | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 1.2M | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 2M | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 513.8k | $0.00 | $0 | | 06/30/2020 |
| 04/03/2020 | Trevi Therapeutics, Inc. | TRVI | Sale | Common Stock | 564 | $2.66 | $1.5k | | 04/03/2020 |
| 04/03/2020 | Trevi Therapeutics, Inc. | TRVI | Exercise (in-the-money or at-the-money) | Call Option (right to buy) | 1.5M | $0.00 | $1.5k | | 04/03/2020 |
| 07/22/2019 | Mirum Pharmaceuticals, Inc. | MIRM | Conversion | Common Stock | 3.7M | $0.00 | $0 | | 07/22/2019 |
| 07/22/2019 | Mirum Pharmaceuticals, Inc. | MIRM | Purchase | Common Stock | 450k | $15.00 | $6.8M | | 07/22/2019 |
| 07/22/2019 | Mirum Pharmaceuticals, Inc. | MIRM | Conversion | Series A Preferred Stock | 29.9M | $0.00 | $0 | | 07/22/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series C Preferred Stock | 17.1M | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Common Stock | 1.9M | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 1000k | $10.00 | $10M | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 1.5M | $10.00 | $15M | | 05/09/2019 |
| 02/14/2019 | GENOCEA BIOSCIENCES, INC. | GNCA | Purchase | Common Stock | 9.9M | $0.47 | $4.7M | | 02/14/2019 |
| 02/14/2019 | GENOCEA BIOSCIENCES, INC. | GNCA | Purchase | Warrant to Purchase Common Stock | 2.5M | $0.57 | $1.4M | | 02/14/2019 |
|